A Multi-Center, Open-Label, Single-Arm, Phase IV Study to Evaluate the Safety and Clinical Efficacy of Oral Administration With Nemonoxacin in Treating Elderly Patients With Community-Acquired Pneumonia
Latest Information Update: 01 Dec 2021
At a glance
- Drugs Nemonoxacin (Primary)
- Indications Community-acquired pneumonia
- Focus Adverse reactions
- Sponsors TaiGen Biotechnology
Most Recent Events
- 01 Dec 2021 New trial record